levity compounded semaglutide Demand Rising for 'Bootlegged' Weight-Loss Drug Semaglutide | Liberty

No more guessing

Retatrutide: The Phase 2 Trial Retatrutides most prominent data comes from a Phase 2 dose-finding trial published in the New England Journal of Medicine in 2023

Retatrutide Side Effects In clinical trials, the most commonly reported side effects were gastrointestinal symptoms, which are similar to those seen with other GLP-1based medications

The Bottom Line For patients and clinicians, the choice between these therapies depends on: Desired weight loss Convenience and preference (oral vs injectable) Tolerance of side effects Insurance and accessibility Retatrutide leads in efficacy but may bring more side effects